CLP-3094
Product Specifications
Background
GPR142 is highly expressed in the pancreas and immune system and shares 33% homology with GPR1391. Endogenous agonists identified to date include aromatic amino acids such as tryptophan and phenylalanine2. CLP-3094 was identified as a potent and selective GPR142 antagonist with an IC50=2.3 M against 1 mM L-tryptophan. It inhibited insulin secretion from islets induced by L-tryptophan and other agonists and displayed anti-inflammatory activity in a mouse arthritis model.3
Conjugation
Unconjugated
Buffer
Off-white solid
Storage Conditions
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6412264-01 0.1 mL
CPE (Carboxypeptidase E, Carboxypeptidase H, CPE, CPH, Enkephalin Convertase) (Biotin)
Sign In for Pricing
View Details MBS6412264-02 5x 0.1 mL
CPE (Carboxypeptidase E, Carboxypeptidase H, CPE, CPH, Enkephalin Convertase) (Biotin)
Sign In for Pricing
View Details 
226862-ML750 100 µL
CA 19-9 (Cancer, Cancer antigen 19-9, CA 199) (MaxLight 750) discontinued
Sign In for Pricing
View Details 
MBS1329044-01 0.05 mg (E-Coli)
Recombinant Ashbya gossypii Survival factor 1 (SVF1)
Sign In for Pricing
View Details MBS1329044-02 0.05 mg (Yeast)
Recombinant Ashbya gossypii Survival factor 1 (SVF1)
Sign In for Pricing
View Details MBS1329044-03 0.05 mg (Baculovirus)
Recombinant Ashbya gossypii Survival factor 1 (SVF1)
Sign In for Pricing
View Details